In the last trading session, 1.12 million shares of the RXO Inc (NYSE:RXO) were traded, and its beta was 1.69. Most recently the company’s share price was $13.99, and it changed around $0.31 or 2.27% from the last close, which brings the market valuation of the company to $2.29B. RXO currently trades at a discount to its 52-week high of $32.82, offering almost -134.6% off that amount. The share price’s 52-week low was $12.39, which indicates that the current value has risen by an impressive 11.44% since then. We note from RXO Inc’s average daily trading volume that its 10-day average is 2.2 million shares, with the 3-month average coming to 1.43 million.
RXO Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.95. If we narrow it down even further, the data shows that 2 out of 22 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 14 recommended RXO as a Hold, whereas 4 deemed it a Buy, and 1 rated it as Underweight. RXO Inc is expected to report earnings per share of -0.02 for the current quarter.
RXO Inc (NYSE:RXO) trade information
Instantly RXO has showed a green trend with a performance of 2.27% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 15.19 on recent trading dayincreased the stock’s daily price by 7.9%. The company’s shares are currently down -41.32% year-to-date, but still down -1.55% over the last five days. On the other hand, RXO Inc (NYSE:RXO) is -24.21% down in the 30-day period. We can see from the shorts that 9.19 million shares have been sold at a short interest cover period of 6.62 day(s).
The consensus price target as assigned by Wall Street analysts is $28, which translates to bulls needing to increase their stock price by 50.04% from its current value. Analyst projections state that RXO is forecast to be at a low of $19 and a high of $29.
RXO Inc (RXO) estimates and forecasts
The year-over-year growth rate is expected to be 42.01%, up from the previous year.
Consensus estimates provided by 15 financial analysts predict the company will bring in an average of 1.49B in revenue for the current quarter. 15 analysts expect RXO Inc to make 1.55B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 913M and 930M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 63.38%. Forecasts for the next quarter put sales growth at 66.58%.
RXO Inc earnings are expected to increase by 84.83% in 2025, but the outlook is positive 97.98% per year for the next five years.
RXO Dividends
RXO Inc’s next quarterly earnings report is expected to be released on 2025-Feb-04.
RXO Inc (NYSE:RXO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.15% of RXO Inc shares, and 106.31% of them are in the hands of institutional investors. The stock currently has a share float of 107.55%. RXO Inc stock is held by 381.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 15.1802% of the shares, which is about 17.85 million shares worth $466.74 million.
ORBIS ALLAN GRAY LTD, with 15.1266% or 17.79 million shares worth $465.1 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 8.76 shares worth $122.56 million, making up 5.34% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 5.06 shares worth around $70.74 million, which represents about 3.08% of the total shares outstanding.
